We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor.
sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBCPrecedent-setting submission includes data from post-marketing studies COBALT and Study 401...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0.08 | 0.422832980973 | 18.92 | 19.02 | 18.89 | 1959749 | 18.96402246 | CS |
52 | 0.7 | 3.82513661202 | 18.3 | 19.02 | 8.8216 | 1690411 | 14.90520764 | CS |
156 | -2.25 | -10.5882352941 | 21.25 | 22.36 | 8.8216 | 1049490 | 15.85991834 | CS |
260 | -70.03 | -78.6588790295 | 89.03 | 125 | 8.8216 | 927810 | 30.79829761 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions